Lead: Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients

Lead Story:

Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients 

JAMA Network Open

In this cohort study of 537 patients, all patients with novel potent opioid (NPO) overdose presented with opioid overdose symptoms and received multiple doses of naloxone. Compared with fentanyl overdose, patients with NPO overdose had a higher number of naloxone doses administered in-hospital; metonitazene overdose was associated with cardiac arrest and more naloxone doses overall. These findings suggest that NPOs may have a higher potency than fentanyl due to the observed naloxone administration in the clinical setting of overdose.

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM